Panzeri et al. use a Trim28 +/D9 mouse model with intrinsic developmental heterogeneity to show that ‘heavy’ and ‘light’ developmental morphs exhibit different timing, type and severity of cancer, linked to a relevant DNA hypomethylation signature.
TRIM28-dependent developmental heterogeneity determines cancer susceptibility through distinct epigenetic states
Posted in biotech/medical, genetics